16 June 2020 Analysis
In December 2019, French start-up Diabeloop announced they had secured €31m Series B funding (a record for a European therapeutic AI company). Its device, which has been described as an...
26 May 2020 Deals Analysis
Healthcare-focused investment firm the Ally Bridge Group has led three separate funding rounds totalling over $150m into medtech companies with a significant role to play in the Covid-19 pandemic. Verdict...
11 May 2020 Comment
The continuous glucose monitoring (CGM) devices market is set to grow robustly regardless of the major upheaval caused by the Covid-19 pandemic. According to GlobalData’s analysis, the global CGM market...
10 March 2020 Analysis
Insulin-based drugs alone have struggled to genuinely improve outcomes for diabetes patients. As a result, Sanofi has committed itself to finding new, technological solutions to help patients better self-manage their...
19 February 2020 News
Abbott and Insulet are partnering to integrate Abbott’s blood glucose sensing technology with Insulet’s Omnipod Horizon automated insulin delivery (AID) system.
6 February 2020 News
German healthcare company Fresenius Kabi has introduced its Glucagon Emergency Kit in the US to treat sudden hypoglycaemic episodes in diabetic patients.
28 January 2020 News
A minimally invasive endoscopic procedure to treat type II diabetes is now available to self-paying patients at London’s Princess Grace Hospital.
15 January 2020 Analysis
The mental strain of diabetes is hard to imagine for those who don’t have the condition, with 25% of diabetics reported to have depression and 40% diagnosed with anxiety. Verdict...
14 January 2020 Analysis
A new generation of patients are demanding medical interventions that not only make it easier to manage medical conditions, but also enhance their day-to-day lives. Engineers and researchers have responded...